Press release
Pharmaceutical Contract Manufacturing Market-Technological Advancement Accelerates the Growth of the Market
Also known as Contract Development and Manufacturing Organization (CDMO), Contract Manufacturing Organization (CMO), is a company serves another companies in the pharmaceutical industry, on a contract basis. The company provide comprehensive services from drug development through drug manufacturing. Many of the pharmaceutical companies are now outsourcing various business aspects. This helps the company to focus on drug discovery, and drug marketing.Contract pharmaceutical manufacturing has evolved largely from last few years. Manufacturing of generic as well as branded drugs, thus reducing the demand and supply gap. Generic drugs are most commonly preferred by the patients as they are cheaper than the branded drugs. Growing demand for generic drugs, and competition and economics of production and trade are major drivers for the growth of the market. Additionally, urge of new product development through technological advancement also fuels the market growth. However, the market is restrained by factors such as high cost of labour, structural changes in industry and employment, standardization and interoperability, and others.
According to Bloomberg, in 2020, USD 60 billion of drug sales are expected to be threatened by generics. In 2016, adalimumab, ledipasvir/sofosbuvir, rituximab, bevacizumab, trastuzumab are the drugs that lost patents.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1532 .
Key players in the Global Pharmaceutical Contract Manufacturing market
Catalant, Boehringer Ingelheim, Lonza AG, Grifols International, S.A, AbbVie Inc, Patheon Inc., Vetter, Pharmaceutical Product Development and others are key players in the market.
Key Developments
Strategic approaches adopted help the major players to sustain their growth in the market and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
Boehringer Ingelheim
Boehringer Ingelheim is focused on research, development, and manufacturing of new medications with high therapeutic value for people and animals. The company has a vast product portfolio in the healthcare industry. The company also has wide geographic presence as it operates across the world. With the huge workforce of around 50,000+ employees. They have a significant presence in North America, Europe, the Middle East & Africa, with commercial, manufacturing, and research facilities in more than one dozen countries.
September, 2017: Boehringer Ingelheim received positive CHMP opinion for adalimumab biosimilar CYLTEZO
September, 2017: Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments
August, 2017: Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm)
Lonza AG
September, 2017: Lonza AG and Portola Pharmaceuticals sign strategic long-term manufacturing agreement to secure supply of AndexXa
August, 2017: Lonza AG to increase and expand capabilities for drug product services for parenteral dosage forms
August, 2017: Lonza AG acquired Micro-Macinazione to become a global leader in micronization capacity and capabilities
Dalton Pharma Services
Dalton Pharma Services is a company offering full range of services in-house such as drug discovery, flow chemistry, formulation and process development, custom synthesis, cGMP sterile fill/finish, cGMP API manufacturing and/or dosage form manufacturing
September, 2017: Dalton Pharma Services announced a drug development and GMP manufacturing services agreement with Arch Biopartners
February, 2017: Dalton Pharma Services Wins 2017 CMO leadership awards
January, 2017: Dalton Pharma Services announced drug development and manufacturing services agreement with Cerium Pharmaceuticals
December, 2016: Dalton Pharma Services entered into agreement with the USAMMDA in support of the US Army’s Drug Development Program
August, 2017: Dalton Pharma Services announced the completion of a major expansion with the completion of a USD 5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.
June 2016: Dalton Pharma Services announced addition of flow chemistry technology
Browse Complete Report at https://www.marketresearchfuture.com/reports/pharmaceutical-contract-manufacturing-market-1532 .
Competitive Landscape
There are numerous players operating in this global pharmaceutical contract manufacturing market. Many organizations especially in North American and Asian region rely on contract manufacturing units for drugs, devices and equipment’s in the healthcare industry. As there are plenty of large and small market players available, it‘s very tricky to analyses their market shares in the global market, but through this market study some major players operating in this market.
Pharmaceutical Contract Manufacturing Market in Asia Pacific
Asia Pacific exhibits tremendous growth opportunities in the market which is attributed to the extensive growth of pharmaceutical industry, increasing number of key players in the market, and rising healthcare expenditure. According to India Brand Equity Foundation, the Indian Pharmaceutical market is expected to grow to USD 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size. Branded generics are expected to constitute nearly 80 per cent of the market share in terms of revenues.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Contract Manufacturing Market-Technological Advancement Accelerates the Growth of the Market here
News-ID: 927507 • Views: …
More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035.
Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial…

Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035.
Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are…

Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034.
Cheese packaging…

Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…